Do you want to know something about Almirall? These are the questions people most often ask of us.
1.- Who is Almirall?
Almirall is a global company based in Barcelona dedicated to providing valuable medicines through its R&D, agreements and alliances. Our work covers the whole of the drug value chain. A consolidated profitable growth allows us to devote our talent and efforts towards specialty areas and particularly to further grow as a leading dermatology player. We are a specialist company, which enables us to succeed in taking our innovative products wherever they are needed.
2.- What is Almirall's mission and vision?
At Almirall we are aware that the promises made in our mission statement go hand in hand with the company's vision. Our talent and efforts address our mission to apply science to provide medical solutions to you and future generations. In order to turn challenges into success stories, our vision is to become a leading specialty company with a strong focus on skin health by addressing the needs of healthcare professionals and those they help.
In terms of strategic direction, we want to focus our resources in:
Propelling our growth in Dermatology while maximizing the value of our existing portfolio
Effectively leveraging and combining business development and R&D actions
Selectively expanding in key countries
Gaining competitive advantage through customer affinity
Fostering a quality and results-oriented organisation with a culture based on being Caring, Dedication, Dynamic and Expert.
3.- How many countries are Almirall's medicines available in?
Almirall's medicinal products are marketed in over 70 countries on the five continents.
4.- Where are its affiliates?
In Austria, Belgium, France, Germany, Italy, the Netherlands, Nordic countries, Poland, Portugal, Spain, Switzerland, United Kingdom-Ireland and US. There are 13 affiliates in total, with sales capabilities in 21 countries.
5.- What were Almirall's total revenues & net sales in 2016?
Total revenues in 2016 were €859.3 million, while net sales totalled €764.4 million.
6.- What percentage of Almirall's total income comes from proprietary drugs?
Proprietary research & development drugs represent 77% of Almirall's net sales (2016).
7.- Which therapeutic areas does Almirall mainly focus its R&D on?
At Almirall, we are working to become a leading specialty company with a strong focus on skin health by addressing the needs of healthcare professionals and those they help.
8.- What proportion of its budget does Almirall allot to research and development?
Almirall devotes more than 12.9% of its net sales and more than 14% of its workforce to R&D (2016).
9.- What are Almirall's medicines?
Almirall's top-selling brands of 2016 accounted for over 54.5%, which reflects a balanced portfolio without over-exposure to a single product. Out of the top-selling drugs, eight were proprietary products: Acne franchise, Airtal®, Almax®, Ciclopoli®, Cordran®, Decoderm®, Ebastel® and ThermiGen®. The 77% of the net sales came from proprietary drugs.
10.- What is the size of Almirall's overall workforce?
In 2016, our workforce numbered around 1,975 people. Of these, over 270 work in R&D.
11.- What are Almirall's most important R&D centres?
The Research and Development Centre in Sant Feliu de Llobregat (Barcelona), the Almirall Centre in Reinbeck (Germany) and the R&D Centre in Lugano (Switzerland).